Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/08
End: 06/30/13
Due: 06/30/14
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 10/31/14
Due: 10/31/15
Phase: N/A
Priority: Normal
Start: 09/30/05
End: 01/31/12
Due: 01/31/13
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 12/31/14
Due: 12/31/15
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Treatment Effect of DiaPep277 in Type 1 Diabetes | NCT00644501 | Andromeda Biotech Ltd. | user2@example.com | None | 2008-09-30 | 2013-06-30 | 2014-06-30 | - | - | 2025-07-14 |
| Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults | NCT01103284 | Andromeda Biotech Ltd. | user2@example.com | None | 2010-04-30 | 2014-10-31 | 2015-10-31 | - | - | 2025-07-14 |
| Efficacy Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Patients | NCT00615264 | Andromeda Biotech Ltd. | user2@example.com | None | 2005-09-30 | 2012-01-31 | 2013-01-31 | - | - | 2025-07-14 |
| Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277® | NCT01898286 | Andromeda Biotech Ltd. | user2@example.com | None | 2013-10-31 | 2014-12-31 | 2015-12-31 | - | - | 2025-07-14 |